CopyMark Law Group
4.9/5
Drawing for WCG

USPTO serial 97922801

WCG

Reviewed by CopyMark Law Group

Reg. 8152462Status 700Registered
Filing date
Status date
Registration date
Feb 24, 2026
Examiner
MACDOUGALL, KIERRA RYNNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WCG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

Jessica L. Rothstein GOODWIN PROCTER LLP620 EIGHTH AVENUENEW YORK, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
035providing business administrative procedure services for obtaining descriptions of participants' consents in clinical trials; business assistance for administrative procedures with schedule management of examination participants' visits and examinations, clinical investigators, and clinical participants; providing business administrative assistance for the creation and preservation of clinical trial documents and records related to the trial implementation plan, case report, substitute for recruitment of subjects; Business consulting, management, and planning services in the field of clinical trials, namely, cost analyses of patient insurance coverage for businesses, negotiating business contracts on behalf of research sites; business consulting, management, and planning services in the field of clinical trials, namely, analyzing and reporting possible cost savings in human research study protocol development and possible cost savings in research site identification on behalf of pharmaceutical trial sponsors and contract research organizations, all for business cost management purposes; business consulting, management, and planning services in the field of clinical trials, namely, applying business analytics to determine the appropriate payer coverage and for use in assisting with study budget negotiations for clinical trial sites; business consulting in the field of clinical trial study identification on behalf of clinical trial sites, namely, negotiating business contracts on behalf of clinical trial sites; business consulting in the field of clinical trials, namely, negotiating business contracts on behalf of clinical trial sites; business consulting and management in the field of clinical trials, namely, providing information management services; Business services, namely, formulation of best practices for clinical trial execution and management for the testing of drugs, biologics, and medical devices; management of telephone call centers for others; preparation of business reports related to key trends and innovations in clinical trial execution and management for the testing of drugs, biologics, and medical devices; Professional staffing services and staff management of institutional review boards, institutional biosafety committees and conflicts of interest; providing business administrative assistance to the officials within the research site who oversee the human subjects research; negotiating clinical trial business contracts between biopharmaceutical companies, contract research organizations and investigator sites around the world; Administration, billing and reconciliation of accounts on behalf of other clinical trial sites; providing patient retention services for retaining patients in clinical trials; Management and compilation of secure computerised databases of patient medical informationACTIVEJun 12, 2023
036financial management of reimbursement payment for other clinical trial sites; financial management in the field of clinical trials, namely, accounts receivables financing and accounts payable debiting, for clinical trial sites; executing and tracking payments from the research sponsor to its associated research sites for payment for research studies; Financial advisory services, namely, budget negotiation in the field of clinical trials; Financial advisory services, namely, budget negotiation in the field of clinical trials, namely, between biopharmaceutical companies, contract research organizations and investigator sites around the worldACTIVEJun 12, 2023
041Training services in the field of clinical trials; training in the field of pharmaceutical testing relating to training on tested protocols designed to evaluate the abuse potential of pharmaceuticals during clinical testing or general clinical practice; Medical training of clinical professionals; training services to be delivered to participants involved in conducting clinical trials in the medical and pharmaceutical industries; Educational services, namely, providing online learning management courses and highly-specialized training for research professionals in the field of clinical trial research training and compliance; arranging and conducting seminars to prospective clinical trial participants about clinical trials research; providing safety instruction in the field of scientific clinical trials to the officials within the research site who oversee the human subjects during research; staff training, namely, business training for others in the field of clinical trial researchACTIVEJun 12, 2023
042Consulting services for others in the field of implementation project management of testing research protocols designed to evaluate the abuse potential of pharmaceuticals during clinical testing or general clinical practice and the analysis of those results; clinical research consulting and advisory services related to ensuring the safety of pharmaceutical preparations administered to patients during clinical trials; collecting and providing statistical analysis of clinical trial data for clinical research purposes; technical consulting in the field of clinical research trials for the testing of drugs, biologics, and medical devices; providing information on drug clinical trials; Providing online non-downloadable computer software to manage health care research and support information through the Internet; providing temporary use of online non-downloadable software for use in assisting clinical trial sites, namely, providing temporary use of online non-downloadable software for conducting informed patient consent processes and featuring technology that enables potential patient users to access consistent institutional review board (IRB) and clinical trial sponsor approved messages, which helps potential patients make informed decisions regarding their participation in clinical studies; Providing a web site featuring technology enabling internet users to manage and exchange healthcare research information; providing consultation in the development and maintenance of standards required to meet accreditation by others in the field of clinical trials involving human subjects and research protocols relating to same; Scientific study and research in the field of clinical research, namely, providing scientific review of human subjects research protocols as to the design and risks involved; providing computer services in support of clinical trial start-up and management, namely, developing and hosting a web-accessed technology platform used for facilitating communication between clinical trial sponsors, contract research organizations, and clinical trial sites; providing a website featuring technology that enables users to collect, manage and share documents to facilitate communication during clinical trials; Providing temporary use of on-line non-downloadable software for conducting assessment surveys regarding suitability for site participation in clinical trials and utilizing data analytics to select appropriate clinical trial site locations; providing online non-downloadable software for posting, tracking, and accessing reports related to clinical training courses attended by clinical trial clinicians; providing scientific research information services, in the field of clinical trials, to prospective or current clinical trial participants, all for the purpose of increasing participant engagement and retention in clinical trials, and provided via telephone and e-mail; providing scientific research information services, in the field of clinical trials, to prospective or current clinical trial participants, all for clinical assistance and quality assurance purposes, and to increase rater reliability in trials where subjective scales are relied upon to improve rating consistency and trial efficacy; Providing on-line non-downloadable software for executing and tracking payments from the research sponsor to its associated research sites for payment for research studies; scientific research in the nature of evaluation and monitoring, namely, assisting and facilitating clinical trials for others; Graphic design of recruitment advertising materials for others for clinical trials; Implementing and managing enterprise system software applications in the nature of Clinical Trial Management System (CTMS)ACTIVEJun 12, 2023
044Medical evaluation of and medical diagnostic services for potential clinical trial patients with arthritic-based issues; medical evaluation and medical diagnostic testing, monitoring and reporting services of patients with arthritic-based issues for potential participation in clinical trials; providing an on-line database featuring healthcare research informationACTIVEJun 12, 2023
045Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; Regulatory compliance consulting in the field of clinical trials and life sciences research, namely, providing consultation to develop a corrective action plan for research misconduct or issues of noncompliance; legal assistance in the drawing up of global contracts for others for resource placement, supported by technology-driven processes and a network of international attorneys who possess specialized, in-depth knowledge of local languages and regulations; Legal assistance in the drawing up of contracts and legal services in relation to the negotiation of contracts for others, all supported by technology-driven processes and an international network of attorneys who know about specific, in-depth local and regulations; Consulting services in the field of international and federal regulatory compliance requirements and guidelines for personnel safety relating to the protection of the rights and welfare of human subjects of clinical research studiesACTIVEJun 12, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 24, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 24, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 30, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 30, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 7, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 10, 2025IUAFUSE AMENDMENT FILED—
Jun 10, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 10, 2025EXT1SOU EXTENSION 1 FILED—
Jun 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 10, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 29, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 29, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 9, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 30, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 20, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 24, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 24, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 9, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2024DOCKASSIGNED TO EXAMINER—
Jun 5, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance